Zacks: Analysts Expect Motus GI Holdings, Inc. (NASDAQ:MOTS) Will Post Earnings of -$0.11 Per Share

Wall Street analysts expect Motus GI Holdings, Inc. (NASDAQ:MOTS) to report ($0.11) earnings per share (EPS) for the current quarter, according to Zacks. Three analysts have issued estimates for Motus GI’s earnings. The lowest EPS estimate is ($0.12) and the highest is ($0.10). Motus GI reported earnings of ($0.13) per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 15.4%. The business is expected to report its next quarterly earnings results on Thursday, November 11th.

According to Zacks, analysts expect that Motus GI will report full-year earnings of ($0.47) per share for the current financial year, with EPS estimates ranging from ($0.54) to ($0.41). For the next fiscal year, analysts expect that the firm will report earnings of ($0.42) per share, with EPS estimates ranging from ($0.46) to ($0.39). Zacks’ earnings per share averages are a mean average based on a survey of analysts that follow Motus GI.

Motus GI (NASDAQ:MOTS) last released its quarterly earnings results on Thursday, August 12th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.11) by $0.01. Motus GI had a negative return on equity of 73.19% and a negative net margin of 8,058.18%. The company had revenue of $0.10 million during the quarter, compared to analysts’ expectations of $0.08 million.

Several brokerages have recently commented on MOTS. Piper Sandler reduced their target price on Motus GI from $2.50 to $1.50 and set an “overweight” rating for the company in a report on Thursday, August 12th. Zacks Investment Research downgraded Motus GI from a “buy” rating to a “hold” rating in a report on Friday, July 16th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $2.00 target price on shares of Motus GI in a report on Thursday, September 9th.

A number of institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC raised its stake in shares of Motus GI by 5.1% during the 1st quarter. Renaissance Technologies LLC now owns 530,684 shares of the company’s stock worth $642,000 after purchasing an additional 25,800 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Motus GI by 59.4% during the 2nd quarter. Geode Capital Management LLC now owns 333,925 shares of the company’s stock worth $347,000 after purchasing an additional 124,458 shares in the last quarter. Virtu Financial LLC purchased a new stake in shares of Motus GI during the 1st quarter worth about $146,000. Neuberger Berman Group LLC purchased a new stake in shares of Motus GI during the 1st quarter worth about $123,000. Finally, Millennium Management LLC purchased a new stake in shares of Motus GI during the 1st quarter worth about $104,000. 15.18% of the stock is owned by hedge funds and other institutional investors.

MOTS stock traded down $0.00 during trading hours on Friday, hitting $0.76. 898 shares of the stock traded hands, compared to its average volume of 2,735,066. Motus GI has a one year low of $0.68 and a one year high of $2.74. The company has a market cap of $36.42 million, a P/E ratio of -1.26 and a beta of 2.58. The stock has a 50-day simple moving average of $0.86 and a 200 day simple moving average of $1.05.

Motus GI Company Profile

Motus GI Holdings, Inc is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

Featured Story: S&P 500 Index

Get a free copy of the Zacks research report on Motus GI (MOTS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Motus GI (NASDAQ:MOTS)

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.